Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy of Nanohydroxyapatite Toothpastes and Cream for Dentin Hypersensitivity
NCT02918617Phase 2Completed
- Sponsor
- UT Health San Antonio
- Start
- May 2015
- Primary completion
- Sep 2016
- Modality
- Hydrogel Systems, Nanoparticles, Device-based Delivery
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of nanohydroxyapatite in dentin hypersensitivity (DH) (9 arms), sponsored by UT Health San Antonio. Primary endpoints: Visual Analog Scale with Air Stimulation at 8 weeks, Visual Analog Scale with Cold Stimulation at 8 weeks and 2 more. Started May 2015; status: completed.
02
Drugs
nanohydroxyapatite
03
Conditions
dentin hypersensitivity (DH)
Beyond the preview
Go deeper on NCT02918617.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02918617.